作者:Byron K. Peters、Jianguo Liu、Cristiana Margarita、Pher G. Andersson
DOI:10.1002/chem.201406523
日期:2015.5.4
The efficient and selective formal total synthesis of aliskiren is described. Aliskiren, a renin inhibitor drug, has received considerable attention, primarily because it is the first of the renin inhibitor drugs to be approved by the FDA. Herein, the formal synthesis of aliskiren by iridium‐catalyzed asymmetric hydrogenation of two allylic alcohol fragments is reported. Screening a number of N,P‐ligated
描述了有效和选择性的正式全合成阿利吉仑。肾素抑制剂药物Aliskiren受到了广泛的关注,主要是因为它是FDA批准的第一种肾素抑制剂药物。本文报道了通过铱催化的两个烯丙基醇片段的不对称氢化来正式合成阿利吉仑的方法。筛选出许多N,P连接的铱催化剂,得到了两种在氢化过程中具有最高对映选择性的催化剂,从而得到了97%和93%ee的饱和醇。氢化后仅四个步骤,通过使用Julia-Kocienski反应将片段合并,以产生后期中间体,总产率为18%。